TrialClinics (Sao Paulo, Brazil)2020

Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial.

Thiago Ramos Grigio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.